Investigational Drug Information for Filibuvir
✉ Email this page to a colleague
What is the drug development status for Filibuvir?
Filibuvir is an investigational drug.
There have been 4 clinical trials for Filibuvir.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Hepatitis C, Hepatitis A, and Hepatitis. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Summary for Filibuvir
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 378 |
WIPO Patent Applications | 236 |
Japanese Patent Applications | 24 |
Clinical Trial Progress | Phase 2 (2009-11-01) |
Vendors | 31 |
Recent Clinical Trials for Filibuvir
Title | Sponsor | Phase |
---|---|---|
Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance | Pfizer | Phase 1 |
Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol) | Pfizer | Phase 1 |
A Study To Investigate Safety And Pharmacokinetics Of A Single Dose Of PF-00868554 (Filibuvir) In Japanese Healthy Adult Volunteers | Pfizer | Phase 1 |
Clinical Trial Summary for Filibuvir
Top disease conditions for Filibuvir
Top clinical trial sponsors for Filibuvir
US Patents for Filibuvir
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |